DuLac Farmaceutici, the Italian pharmaceutical company known for its recovery-focused dermo cosmetic products, is reporting strong consumer demand on Amazon U.S. for its flagship Arnica Gel 98% and Dinaven and Diosmin lines, as the company prepares for broader U.S. market expansion.
With more than 30 years of European pharmaceutical expertise, DuLac Farmaceutici develops advanced wellness and recovery solutions engineered for active lifestyles, vascular wellness, and microcirculation support. The company’s performance on Amazon is a key anchor for its U.S. growth strategy.
DuLac’s Arnica Gel 98% currently maintains an average 4.5-star rating across more than 13,000 Amazon customer reviews, while Dinaven holds an average 4.6-star rating across more than 4,000 customer reviews on the Amazon U.S. platform. This consumer response reflects an increasing market demand for premium recovery products developed with high-concentration active ingredients and Made-in-Italy quality standards.
“U.S. consumers are actively seeking wellness products that bridge the gap between traditional botanical ingredients and rigorous pharmaceutical standards,” said Gabriele Bollani, Founder and CEO of DuLac Farmaceutici. “Our performance on Amazon validates this market fit as we scale our physical retail and wholesale presence across the United States.”
As part of its U.S. commercial expansion, DuLac is introducing the clinical research driving its Dinaven and Diosmin line. The product targets chronic venous insufficiency (CVI) and microcirculation impairment, a systemic condition affecting up to 60% of women and 30% of adult men. Research indicates CVI shares biological pathways with broader cardiovascular challenges, including endothelial inflammation and vascular dysfunction.
To address the low solubility and poor intestinal absorption common in standard diosmin, DuLac utilizes Diosmin MPFF (Micronized Purified Flavonoid Fraction) in its Dinaven formulation. This advanced micronization process reduces the active particle diameter from over 60 µm to under 2 µm, doubling its bioavailability. Clinical data shows that micronized diosmin delivers significantly greater symptom relief for heavy legs, swelling, and cramps compared to non-micronized alternatives.
Additionally, Dinaven and Diosmin targets vascular stasis associated with hemorrhoidal disease, a condition affecting approximately half of adults over 50. Driven by modern sedentary lifestyles, acute flare-ups are increasingly common in younger demographics. By deploying micronized bioflavonoids, Dinaven provides systemic support to reinforce venous walls, counter capillary fragility, and manage localized congestion.
DuLac’s Arnica Gel 98% is an extra-strength cooling massage gel for muscle recovery, formulated with 98% Arnica Montana water alongside natural ingredients including buriti oil, thyme, and menthol. It is widely used by athletes and active individuals for pre- and post-activity joint and muscle comfort.
To stabilize the raw material supply, DuLac moved away from traditional wild harvesting. The company mapped the phytocomplex of spontaneous Arnica Montana at high altitudes (2,200 meters) to isolate Helenalin, the primary active compound responsible for inhibiting inflammatory mediators. To ensure purity and environmental sustainability, DuLac replicates these high-altitude conditions indoors via a state-of-the-art Vertical Farm. This controlled agricultural method expands production from a single annual harvest to 8-10 continuous harvests per year. The process guarantees seasonal consistency, a 95% reduction in water usage, and a completely pesticide-free raw material.
To process these botanicals without thermal degradation, DuLac employs Supercritical CO₂ Extraction. Operating at low temperatures without harsh chemical solvents, this system yields a pure concentrate for precise active ingredient dosing. This proprietary process yields Arnica Arricchita™, which has demonstrated significantly higher biological efficacy in laboratory testing compared to standard extracts.
As part of its broader U.S. growth strategy, DuLac plans to continue expanding awareness and distribution across additional retail, e-commerce, wellness, and recovery-focused channels in the coming months. More information can be found at DuLac Farmaceutici USA and through the company’s Amazon Storefront.
This news story relied on content distributed by Newsworthy.ai. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is DuLac Farmaceutici Sees Strong Amazon Demand as It Prepares for Broader U.S. Expansion.